The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization.
Angiogenesis
Arteriogenesis
Coronary artery bypass graft
Myocardial infarction
Myocardial revascularization
Percutaneous coronary intervention
Journal
Journal of cardiovascular translational research
ISSN: 1937-5395
Titre abrégé: J Cardiovasc Transl Res
Pays: United States
ID NLM: 101468585
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
25
12
2021
accepted:
18
03
2022
pubmed:
1
4
2022
medline:
3
11
2022
entrez:
31
3
2022
Statut:
ppublish
Résumé
Surgical myocardial revascularization is associated with long-term survival benefit in patients with multivessel coronary artery disease. However, the exact biological mechanisms underlying the clinical benefits of myocardial revascularization have not been elucidated yet. Angiogenesis and arteriogenesis biologically leading to vascular collateralization are considered one of the endogenous mechanisms to preserve myocardial viability during ischemia, and the presence of coronary collateralization has been regarded as one of the predictors of long-term survival in patients with coronary artery disease (CAD). Some experimental studies and indirect clinical evidence on chronic CAD confirmed an angiogenetic response induced by myocardial revascularization and suggested that revascularization procedures could constitute an angiogenetic trigger per se. In this review, the clinical and basic science evidence regarding arteriogenesis and angiogenesis in both CAD and coronary revascularization is analyzed with the aim to better elucidate their significance in the clinical arena and potential therapeutic use.
Identifiants
pubmed: 35357670
doi: 10.1007/s12265-022-10241-0
pii: 10.1007/s12265-022-10241-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1024-1048Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Gaudino, M., Hameed, I., Farkouh, M. E., Rahouma, M., Naik, A., Robinson, N. B., Ruan, Y., Demetres, M., Biondi-Zoccai, G., Angiolillo, D. J., Bagiella, E., Charlson, M. E., Benedetto, U., Ruel, M., Taggart, D. P., Girardi, L. N., Bhatt, D. L., & Fremes, S. E. (2020). Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis. JAMA Internal Medicine, 180, 1638–1646. https://doi.org/10.1001/jamainternmed.2020.4748
doi: 10.1001/jamainternmed.2020.4748
pubmed: 33044497
pmcid: 7551235
Doenst, T., Haverich, A., Serruys, P., Bonow, R. O., Kappetein, P., Falk, V., Velazquez, E., Diegeler, A., & Sigusch, H. (2019). PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. Journal of the American College of Cardiology, 73, 964–976. https://doi.org/10.1016/j.jacc.2018.11.053
doi: 10.1016/j.jacc.2018.11.053
pubmed: 30819365
Glineur, D., Grau, J. B., Etienne, P. Y., Benedetto, U., Fortier, J. H., Papadatos, S., Laruelle, C., Pieters, D., El Khoury, E., Blouard, P., Timmermans, P., Ruel, M., Chong, A. Y., So, D., Chan, V., Rubens, F., & Gaudino, M. F. (2019). Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: The IMPAG trial. European Heart Journal, 40, 2421–2428. https://doi.org/10.1093/eurheartj/ehz329
doi: 10.1093/eurheartj/ehz329
pubmed: 31155673
Glineur, D., Rahouma, M., Grau, J. B., Etienne, P. Y., Fortier, J. H., Papadatos, S., Laruelle, C., Pieters, D., El Khoury, E., & Gaudino, M. (2020). FFR Cutoff by Arterial Graft Configuration and Location: IMPAG Trial Insights. JACC. Cardiovascular Interventions, 13, 143–144. https://doi.org/10.1016/j.jcin.2019.08.013
doi: 10.1016/j.jcin.2019.08.013
pubmed: 31918937
Lopes, R. D., Mehta, R. H., Hafley, G. E., Williams, J. B., Mack, M. J., Peterson, E. D., Allen, K. B., Harrington, R. A., Gibson, C. M., Califf, R. M., Kouchoukos, N. T., Ferguson, T. B., Jr., & Alexander, J. H. (2012). Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation, 125, 749–756. https://doi.org/10.1161/circulationaha.111.040311
doi: 10.1161/circulationaha.111.040311
pubmed: 22238227
pmcid: 3699199
Gaudino, M., Antoniades, C., Benedetto, U., Deb, S., Di Franco, A., Di Giammarco, G., Fremes, S., Glineur, D., Grau, J., He, G. W., Marinelli, D., Ohmes, L. B., Patrono, C., Puskas, J., Tranbaugh, R., Girardi, L. N., & Taggart, D. P. (2017). Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Circulation, 136, 1749–1764. https://doi.org/10.1161/circulationaha.117.027597
doi: 10.1161/circulationaha.117.027597
pubmed: 29084780
Spadaccio, C., Antoniades, C., Nenna, A., Chung, C., Will, R., Chello, M., & Gaudino, M. F. L. (2020). Preventing treatment failures in coronary artery disease: What can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries? Cardiovascular Research, 116, 505–519. https://doi.org/10.1093/cvr/cvz214
doi: 10.1093/cvr/cvz214
pubmed: 31397850
Allahwala, U. K., Khachigian, L. M., Nour, D., Ridiandres, A., Billah, M., Ward, M., Weaver, J., & Bhindi, R. (2020). Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis. Microvascular Research, 132, 104058. https://doi.org/10.1016/j.mvr.2020.104058
doi: 10.1016/j.mvr.2020.104058
pubmed: 32798552
Allahwala, U. K., Kott, K., Bland, A., Ward, M., & Bhindi, R. (2020). Predictors and Prognostic Implications of Well-Matured Coronary Collateral Circulation in Patients with a Chronic Total Occlusion (CTO). International Heart Journal, 61, 223–230. https://doi.org/10.1536/ihj.19-456
doi: 10.1536/ihj.19-456
pubmed: 32173707
Merkus, D., Muller-Delp, J., & Heaps, C. L. (2021). Coronary microvascular adaptations distal to epicardial artery stenosis. American Journal of Physiology. Heart and Circulatory Physiology, 320, H2351–H2370. https://doi.org/10.1152/ajpheart.00992.2020
doi: 10.1152/ajpheart.00992.2020
pubmed: 33961506
pmcid: 8289363
Seiler, C., Stoller, M., Pitt, B., & Meier, P. (2013). The human coronary collateral circulation: Development and clinical importance. European Heart Journal, 34, 2674–2682. https://doi.org/10.1093/eurheartj/eht195
doi: 10.1093/eurheartj/eht195
pubmed: 23739241
Schaper, W., & Scholz, D. (2003). Factors regulating arteriogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1143–1151. https://doi.org/10.1161/01.atv.0000069625.11230.96
doi: 10.1161/01.atv.0000069625.11230.96
pubmed: 12676799
Carmeliet, P., & Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature, 473, 298–307. https://doi.org/10.1038/nature10144
doi: 10.1038/nature10144
pubmed: 21593862
pmcid: 4049445
Herbert, S. P., & Stainier, D. Y. (2011). Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nature Reviews Molecular Cell Biology, 12, 551–564. https://doi.org/10.1038/nrm3176
doi: 10.1038/nrm3176
pubmed: 21860391
pmcid: 3319719
Jamaiyar, A., Juguilon, C., Wan, W., Richardson, D., Chinchilla, S., Gadd, J., Enrick, M., Wang, T., McCabe, C., Wang, Y., Kolz, C., Clark, A., Thodeti, S., Ohanyan, V., Dong, F., Zhou, B., Chilian, W., & Yin, L. (2022). The essential role for endothelial cell sprouting in coronary collateral growth. Journal of Molecular and Cellular Cardiology, 165, 158–171. https://doi.org/10.1016/j.yjmcc.2022.01.005
doi: 10.1016/j.yjmcc.2022.01.005
pubmed: 35074317
Page, D. J., Thuret, R., Venkatraman, L., Takahashi, T., Bentley, K., & Herbert, S. P. (2019). Positive Feedback Defines the Timing, Magnitude, and Robustness of Angiogenesis. Cell Reports, 27, 3139-3151.e3135. https://doi.org/10.1016/j.celrep.2019.05.052
doi: 10.1016/j.celrep.2019.05.052
pubmed: 31189101
Dragneva, G., Korpisalo, P., & Yla-Herttuala, S. (2013). Promoting blood vessel growth in ischemic diseases: Challenges in translating preclinical potential into clinical success. Disease Models & Mechanisms, 6, 312–322. https://doi.org/10.1242/dmm.010413
doi: 10.1242/dmm.010413
Cao, X., Li, B., Han, X., Zhang, X., Dang, M., Wang, H., Du, F., Zeng, X., & Guo, C. (2020). Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury. Apoptosis, 25, 341–353. https://doi.org/10.1007/s10495-020-01602-8
doi: 10.1007/s10495-020-01602-8
pubmed: 32333220
Chang H, Li ZB, Wu JY, Zhang L (2020) Circ-100338 induces angiogenesis after myocardial ischemia-reperfusion injury by sponging miR-200a-3p. Eur Rev Med Pharmacol Sci 24:6323–6332. https://doi.org/10.26355/eurrev_202006_21530
Chen, M. H., & Fu, Q. M. (2020). The Roles of AMPK in Revascularization. Cardiology Research and Practice, 2020, 4028635. https://doi.org/10.1155/2020/4028635
doi: 10.1155/2020/4028635
pubmed: 32185076
pmcid: 7063202
Geng, T., Song, Z. Y., Xing, J. X., Wang, B. X., Dai, S. P., & Xu, Z. S. (2020). Exosome Derived from Coronary Serum of Patients with Myocardial Infarction Promotes Angiogenesis Through the miRNA-143/IGF-IR Pathway. International Journal of Nanomedicine, 15, 2647–2658. https://doi.org/10.2147/ijn.s242908
doi: 10.2147/ijn.s242908
pubmed: 32368046
pmcid: 7183550
Potz, B. A., Parulkar, A. B., Abid, R. M., Sodha, N. R., & Sellke, F. W. (2017). Novel molecular targets for coronary angiogenesis and ischemic heart disease. Coronary Artery Disease, 28, 605–613. https://doi.org/10.1097/mca.0000000000000516
doi: 10.1097/mca.0000000000000516
pubmed: 28678145
pmcid: 5624824
Chávez, J. C., Agani, F., & Pichiule, P. (1985). LaManna JC (2000) Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. Journal of Applied Physiology, 89, 1937–1942. https://doi.org/10.1152/jappl.2000.89.5.1937
doi: 10.1152/jappl.2000.89.5.1937
Semenza, G. L. (2000). Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. The Journal of Clinical Investigation, 106, 809–812. https://doi.org/10.1172/jci11223
doi: 10.1172/jci11223
pubmed: 11018065
pmcid: 381427
Vogt, M., Puntschart, A., Geiser, J., Zuleger, C., & Billeter, R. (1985). Hoppeler H (2001) Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. Journal of Applied Physiology, 91, 173–182. https://doi.org/10.1152/jappl.2001.91.1.173
doi: 10.1152/jappl.2001.91.1.173
Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., & Keshert, E. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 485–490. https://doi.org/10.1038/28867
doi: 10.1038/28867
pubmed: 9697772
Gerber, H. P., Condorelli, F., Park, J., & Ferrara, N. (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. Journal of Biological Chemistry, 272, 23659–23667. https://doi.org/10.1074/jbc.272.38.23659
doi: 10.1074/jbc.272.38.23659
pubmed: 9295307
Jung, F., Palmer, L. A., Zhou, N., & Johns, R. A. (2000). Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circulation Research, 86, 319–325. https://doi.org/10.1161/01.res.86.3.319
doi: 10.1161/01.res.86.3.319
pubmed: 10679484
Palmer, L. A., Semenza, G. L., Stoler, M. H., & Johns, R. A. (1998). Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. American Journal of Physiology, 274, L212-219. https://doi.org/10.1152/ajplung.1998.274.2.L212
doi: 10.1152/ajplung.1998.274.2.L212
pubmed: 9486205
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., VandenDriessche, T., … Persico, M. G. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Medicine, 7, 575–583. https://doi.org/10.1038/87904
doi: 10.1038/87904
pubmed: 11329059
Khaliq, A., Dunk, C., Jiang, J., Shams, M., Li, X. F., Acevedo, C., Weich, H., Whittle, M., & Ahmed, A. (1999). Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: Molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Laboratory Investigation, 79, 151–170.
pubmed: 10068204
Loughna, S., & Sato, T. N. (2001). Angiopoietin and Tie signaling pathways in vascular development. Matrix Biology, 20, 319–325. https://doi.org/10.1016/s0945-053x(01)00149-4
doi: 10.1016/s0945-053x(01)00149-4
pubmed: 11566266
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature, 407, 242–248. https://doi.org/10.1038/35025215
doi: 10.1038/35025215
pubmed: 11001067
Arras, M., Ito, W. D., Scholz, D., Winkler, B., Schaper, J., & Schaper, W. (1998). Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. The Journal of Clinical Investigation, 101, 40–50. https://doi.org/10.1172/jci119877
doi: 10.1172/jci119877
pubmed: 9421464
pmcid: 508538
Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nature Medicine, 6, 389–395. https://doi.org/10.1038/74651
doi: 10.1038/74651
pubmed: 10742145
Guo, M., Shi, J. H., Wang, P. L., & Shi, D. Z. (2018). Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. Journal of Cardiovascular Pharmacology and Therapeutics, 23, 130–141. https://doi.org/10.1177/1074248417735399
doi: 10.1177/1074248417735399
pubmed: 29025278
Askin L, Tibilli H, Tanriverdi O, Turkmen S (2020) The relationship between coronary artery disease and SIRT1 protein. North Clin Istanb 7:631–635. https://doi.org/10.14744/nci.2020.31391
Laderoute, K. R., Alarcon, R. M., Brody, M. D., Calaoagan, J. M., Chen, E. Y., Knapp, A. M., Yun, Z., Denko, N. C., & Giaccia, A. J. (2000). Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clinical Cancer Research, 6, 2941–2950.
pubmed: 10914744
Wu, P., Yonekura, H., Li, H., Nozaki, I., Tomono, Y., Naito, I., Ninomiya, Y., & Yamamoto, H. (2001). Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochemical and Biophysical Research Communications, 288, 1149–1154. https://doi.org/10.1006/bbrc.2001.5903
doi: 10.1006/bbrc.2001.5903
pubmed: 11700031
Silvestre, J. S., Smadja, D. M., & Levy, B. I. (2013). Postischemic revascularization: From cellular and molecular mechanisms to clinical applications. Physiological Reviews, 93, 1743–1802. https://doi.org/10.1152/physrev.00006.2013
doi: 10.1152/physrev.00006.2013
pubmed: 24137021
Pries, A. R., & Secomb, T. W. (2014). Making microvascular networks work: Angiogenesis, remodeling, and pruning. Physiology (Bethesda, Md.), 29, 446–455. https://doi.org/10.1152/physiol.00012.2014
doi: 10.1152/physiol.00012.2014
Cochain, C., Rodero, M. P., Vilar, J., Récalde, A., Richart, A. L., Loinard, C., Zouggari, Y., Guérin, C., Duriez, M., Combadière, B., Poupel, L., Lévy, B. I., Mallat, Z., Combadière, C., & Silvestre, J. S. (2010). Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovascular Research, 88, 186–195. https://doi.org/10.1093/cvr/cvq153
doi: 10.1093/cvr/cvq153
pubmed: 20501509
Frangogiannis, N. G. (2006). Targeting the inflammatory response in healing myocardial infarcts. Current Medicinal Chemistry, 13, 1877–1893. https://doi.org/10.2174/092986706777585086
doi: 10.2174/092986706777585086
pubmed: 16842199
Silvestre, J. S., Mallat, Z., Duriez, M., Tamarat, R., Bureau, M. F., Scherman, D., Duverger, N., Branellec, D., Tedgui, A., & Levy, B. I. (2000). Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circulation Research, 87, 448–452. https://doi.org/10.1161/01.res.87.6.448
doi: 10.1161/01.res.87.6.448
pubmed: 10988235
Silvestre, J. S., Mallat, Z., Tamarat, R., Duriez, M., Tedgui, A., & Levy, B. I. (2001). Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: Role in ischemia-induced angiogenesis. Circulation Research, 89, 259–264. https://doi.org/10.1161/hh1501.094269
doi: 10.1161/hh1501.094269
pubmed: 11485976
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research, 94, 1543–1553. https://doi.org/10.1161/01.RES.0000130526.20854.fa
doi: 10.1161/01.RES.0000130526.20854.fa
pubmed: 15217919
Kobayashi, T., Watanabe, Y., Saito, Y., Fujioka, D., Nakamura, T., Obata, J. E., Kitta, Y., Yano, T., Kawabata, K., Watanabe, K., Mishina, H., Ito, S., & Kugiyama, K. (2010). Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury. Cardiovascular Research, 85, 785–795. https://doi.org/10.1093/cvr/cvp342
doi: 10.1093/cvr/cvp342
pubmed: 19837697
Ingason, A. B., Goldstone, A. B., Paulsen, M. J., Thakore, A. D., Truong, V. N., Edwards, B. B., Eskandari, A., Bollig, T., Steele, A. N., & Woo, Y. J. (2018). Angiogenesis precedes cardiomyocyte migration in regenerating mammalian hearts. Journal of Thoracic and Cardiovascular Surgery, 155, 1118-1127.e1111. https://doi.org/10.1016/j.jtcvs.2017.08.127
doi: 10.1016/j.jtcvs.2017.08.127
pubmed: 29452461
Schaper, W. (2009). Collateral circulation: Past and present. Basic Research in Cardiology, 104, 5–21. https://doi.org/10.1007/s00395-008-0760-x
doi: 10.1007/s00395-008-0760-x
pubmed: 19101749
pmcid: 2755790
Deindl, E., Buschmann, I., Hoefer, I. E., Podzuweit, T., Boengler, K., Vogel, S., van Royen, N., Fernandez, B., & Schaper, W. (2001). Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circulation Research, 89, 779–786. https://doi.org/10.1161/hh2101.098613
doi: 10.1161/hh2101.098613
pubmed: 11679407
Eitenmüller, I., Volger, O., Kluge, A., Troidl, K., Barancik, M., Cai, W. J., Heil, M., Pipp, F., Fischer, S., Horrevoets, A. J., Schmitz-Rixen, T., & Schaper, W. (2006). The range of adaptation by collateral vessels after femoral artery occlusion. Circulation Research, 99, 656–662. https://doi.org/10.1161/01.RES.0000242560.77512.dd
doi: 10.1161/01.RES.0000242560.77512.dd
pubmed: 16931799
Pipp, F., Boehm, S., Cai, W. J., Adili, F., Ziegler, B., Karanovic, G., Ritter, R., Balzer, J., Scheler, C., Schaper, W., & Schmitz-Rixen, T. (2004). Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1664–1668. https://doi.org/10.1161/01.ATV.0000138028.14390.e4
doi: 10.1161/01.ATV.0000138028.14390.e4
pubmed: 15242864
Wu, S. H., Zhang, F., Yao, S., Tang, L., Zeng, H. T., Zhu, L. P., & Yang, Z. (2020). Shear Stress Triggers Angiogenesis of Late Endothelial Progenitor Cells via the PTEN/Akt/GTPCH/BH4 Pathway. Stem Cells Int, 2020, 5939530. https://doi.org/10.1155/2020/5939530
doi: 10.1155/2020/5939530
pubmed: 32399044
pmcid: 7210539
Gloekler, S., Meier, P., de Marchi, S. F., Rutz, T., Traupe, T., Rimoldi, S. F., Wustmann, K., Steck, H., Cook, S., Vogel, R., Togni, M., & Seiler, C. (2010). Coronary collateral growth by external counterpulsation: A randomised controlled trial. Heart, 96, 202–207. https://doi.org/10.1136/hrt.2009.184507
doi: 10.1136/hrt.2009.184507
pubmed: 19897461
Grundmann, S., Piek, J. J., Pasterkamp, G., & Hoefer, I. E. (2007). Arteriogenesis: Basic mechanisms and therapeutic stimulation. European Journal of Clinical Investigation, 37, 755–766. https://doi.org/10.1111/j.1365-2362.2007.01861.x
doi: 10.1111/j.1365-2362.2007.01861.x
pubmed: 17764463
Heil, M., Ziegelhoeffer, T., Pipp, F., Kostin, S., Martin, S., Clauss, M., & Schaper, W. (2002). Blood monocyte concentration is critical for enhancement of collateral artery growth. American Journal of Physiology. Heart and Circulatory Physiology, 283, H2411-2419. https://doi.org/10.1152/ajpheart.01098.2001
doi: 10.1152/ajpheart.01098.2001
pubmed: 12388258
Troidl, K., Hammerschick, T., Albarran-Juarez, J., Jung, G., Schierling, W., Tonack, S., Kruger, M., Matuschke, B., Troidl, C., Schaper, W., Schmitz-Rixen, T., Preissner, K. T., & Fischer, S. (2020). Shear Stress-Induced miR-143-3p in Collateral Arteries Contributes to Outward Vessel Growth by Targeting Collagen V-alpha2. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, e126–e137. https://doi.org/10.1161/ATVBAHA.120.313316
doi: 10.1161/ATVBAHA.120.313316
pubmed: 32188276
Hoefer, I. E., van Royen, N., Buschmann, I. R., Piek, J. J., & Schaper, W. (2001). Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovascular Research, 49, 609–617. https://doi.org/10.1016/s0008-6363(00)00243-1
doi: 10.1016/s0008-6363(00)00243-1
pubmed: 11166274
Revelo, X. S., Parthiban, P., Chen, C., Barrow, F., Fredrickson, G., Wang, H., Yucel, D., Herman, A., & van Berlo, J. H. (2021). Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis. Circulation Research, 129, 1086–1101. https://doi.org/10.1161/CIRCRESAHA.121.319737
doi: 10.1161/CIRCRESAHA.121.319737
pubmed: 34645281
pmcid: 8638822
Vogel, R., Traupe, T., Steiger, V. S., & Seiler, C. (2010). Physical coronary arteriogenesis: A human “model” of collateral growth promotion. Trends in Cardiovascular Medicine, 20, 129–133. https://doi.org/10.1016/j.tcm.2010.10.004
doi: 10.1016/j.tcm.2010.10.004
pubmed: 21335283
Gungor H, Sivri F, Yildirim BO, Cayirli S, Demiroglu O, Yesilkaya CU, Zencir C (2021) The Effects of Preoperative Coronary Collateral Circulation on Cardiac-Related Events after Coronary Artery Bypass Graft Surgery. Braz J Cardiovasc Surg 36:25–31. https://doi.org/10.21470/1678-9741-2019-0375
Chen, S. M., Li, Y. G., Zhang, H. X., Zhang, G. H., Long, J. R., Tan, C. J., Wang, D. M., Fang, X. Y., & Mai, R. Q. (2008). Hypoxia-inducible factor-1alpha induces the coronary collaterals for coronary artery disease. Coronary Artery Disease, 19, 173–179. https://doi.org/10.1097/MCA.0b013e3282fa4b2c
doi: 10.1097/MCA.0b013e3282fa4b2c
pubmed: 18418234
Jurgensen, J. S., Rosenberger, C., Wiesener, M. S., Warnecke, C., Horstrup, J. H., Grafe, M., Philipp, S., Griethe, W., Maxwell, P. H., Frei, U., Bachmann, S., Willenbrock, R., & Eckardt, K. U. (2004). Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. The FASEB Journal, 18, 1415–1417. https://doi.org/10.1096/fj.04-1605fje
doi: 10.1096/fj.04-1605fje
pubmed: 15247145
Kido, M., Du, L., Sullivan, C. C., Li, X., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2005). Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Journal of the American College of Cardiology, 46, 2116–2124. https://doi.org/10.1016/j.jacc.2005.08.045
doi: 10.1016/j.jacc.2005.08.045
pubmed: 16325051
Bao, W., Qin, P., Needle, S., Erickson-Miller, C. L., Duffy, K. J., Ariazi, J. L., Zhao, S., Olzinski, A. R., Behm, D. J., Pipes, G. C., Jucker, B. M., Hu, E., Lepore, J. J., & Willette, R. N. (2010). Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. Journal of Cardiovascular Pharmacology, 56, 147–155. https://doi.org/10.1097/FJC.0b013e3181e2bfef
doi: 10.1097/FJC.0b013e3181e2bfef
pubmed: 20714241
Huang, M., Nguyen, P., Jia, F., Hu, S., Gong, Y., de Almeida, P. E., Wang, L., Nag, D., Kay, M. A., Giaccia, A. J., Robbins, R. C., & Wu, J. C. (2011). Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation, 124, S46-54. https://doi.org/10.1161/CIRCULATIONAHA.110.014019
doi: 10.1161/CIRCULATIONAHA.110.014019
pubmed: 21911818
pmcid: 3181087
Badimon, L., & Borrell, M. (2018). Microvasculature Recovery by Angiogenesis After Myocardial Infarction. Current Pharmaceutical Design, 24, 2967–2973. https://doi.org/10.2174/1381612824666180629162726
doi: 10.2174/1381612824666180629162726
pubmed: 29962335
Skuli, N., Majmundar, A. J., Krock, B. L., Mesquita, R. C., Mathew, L. K., Quinn, Z. L., Runge, A., Liu, L., Kim, M. N., Liang, J., Schenkel, S., Yodh, A. G., Keith, B., & Simon, M. C. (2012). Endothelial HIF-2alpha regulates murine pathological angiogenesis and revascularization processes. The Journal of Clinical Investigation, 122, 1427–1443. https://doi.org/10.1172/jci57322
doi: 10.1172/jci57322
pubmed: 22426208
pmcid: 3314446
Red-Horse, K., & Das, S. (2021). New Research Is Shining Light on How Collateral Arteries Form in the Heart: A Future Therapeutic Direction? Current Cardiology Reports, 23, 30. https://doi.org/10.1007/s11886-021-01460-z
doi: 10.1007/s11886-021-01460-z
pubmed: 33655379
Spadaccio, C., Nappi, F., Nenna, A., Beattie, G., Chello, M., & Sutherland, F. W. (2016). Is it time to change how we think about incomplete coronary revascularization? International Journal of Cardiology, 224, 295–298. https://doi.org/10.1016/j.ijcard.2016.09.055
doi: 10.1016/j.ijcard.2016.09.055
pubmed: 27665400
Piccirillo, F., Carpenito, M., Verolino, G., Chello, C., Nusca, A., Lusini, M., Spadaccio, C., Nappi, F., Di Sciascio, G., & Nenna, A. (2019). Changes of the coronary arteries and cardiac microvasculature with aging: Implications for translational research and clinical practice. Mechanisms of Ageing and Development, 184, 111161. https://doi.org/10.1016/j.mad.2019.111161
doi: 10.1016/j.mad.2019.111161
pubmed: 31647940
Ebrahimian, T. G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L., Duriez, M., Vilar, J., Brandes, R. P., Levy, B. I., Shah, A. M., & Silvestre, J. S. (2006). NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. American Journal of Pathology, 169, 719–728. https://doi.org/10.2353/ajpath.2006.060042
doi: 10.2353/ajpath.2006.060042
pubmed: 16877369
pmcid: 1698801
Haddad, P., Dussault, S., Groleau, J., Turgeon, J., Maingrette, F., & Rivard, A. (2011). Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: Effects on endothelial progenitor cells and mature endothelial cells. Atherosclerosis, 217, 340–349. https://doi.org/10.1016/j.atherosclerosis.2011.03.038
doi: 10.1016/j.atherosclerosis.2011.03.038
pubmed: 21524749
Yoshida, T., Maulik, N., Engelman, R. M., Ho, Y. S., & Das, D. K. (2000). Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circulation Research, 86, 264–269. https://doi.org/10.1161/01.res.86.3.264
doi: 10.1161/01.res.86.3.264
pubmed: 10679476
Liu, X., Sun, X., Liao, H., Dong, Z., Zhao, J., Zhu, H., Wang, P., Shen, L., Xu, L., Ma, X., Shen, C., Fan, F., Wang, C., Hu, K., Zou, Y., Ge, J., Ren, J., & Sun, A. (2015). Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 2196–2206. https://doi.org/10.1161/atvbaha.115.306012
doi: 10.1161/atvbaha.115.306012
pubmed: 26315408
Davidson, S. M., Padro, T., Bollini, S., Vilahur, G., Duncker, D. J., Evans, P. C., Guzik, T., Hoefer, I. E., Waltenberger, J., Wojta, J., & Weber, C. (2021). Progress in cardiac research: From rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovascular Research, 117, 2161–2174. https://doi.org/10.1093/cvr/cvab200
doi: 10.1093/cvr/cvab200
pubmed: 34114614
pmcid: 8344830
Wang, J., Toan, S., & Zhou, H. (2020). New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis, 23, 299–314. https://doi.org/10.1007/s10456-020-09720-2
doi: 10.1007/s10456-020-09720-2
pubmed: 32246225
Souders, C. A., Bowers, S. L., & Baudino, T. A. (2009). Cardiac fibroblast: The renaissance cell. Circulation Research, 105, 1164–1176. https://doi.org/10.1161/circresaha.109.209809
doi: 10.1161/circresaha.109.209809
pubmed: 19959782
pmcid: 3345531
Fukuyama, N., Tanaka, E., Tabata, Y., Fujikura, H., Hagihara, M., Sakamoto, H., Ando, K., Nakazawa, H., & Mori, H. (2007). Intravenous injection of phagocytes transfected ex vivo with FGF4 DNA/biodegradable gelatin complex promotes angiogenesis in a rat myocardial ischemia/reperfusion injury model. Basic Research in Cardiology, 102, 209–216. https://doi.org/10.1007/s00395-006-0629-9
doi: 10.1007/s00395-006-0629-9
pubmed: 17058153
Giordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., DeMaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996). Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Medicine, 2, 534–539. https://doi.org/10.1038/nm0596-534
doi: 10.1038/nm0596-534
pubmed: 8616711
Wu, Z., & Zhu, D. (2014). The important role of catestatin in cardiac remodeling. Biomarkers, 19, 625–630. https://doi.org/10.3109/1354750x.2014.950331
doi: 10.3109/1354750x.2014.950331
pubmed: 25136978
Xu, W., Yu, H., Wu, H., Li, S., Chen, B., & Gao, W. (2017). Plasma Catestatin in Patients with Acute Coronary Syndrome. Cardiology, 136, 164–169. https://doi.org/10.1159/000448987
doi: 10.1159/000448987
pubmed: 27681934
Salvucci, O., & Tosato, G. (2012). Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Advances in Cancer Research, 114, 21–57. https://doi.org/10.1016/b978-0-12-386503-8.00002-8
doi: 10.1016/b978-0-12-386503-8.00002-8
pubmed: 22588055
pmcid: 3500853
Yang, D., Jin, C., Ma, H., Huang, M., Shi, G. P., Wang, J., & Xiang, M. (2016). EphrinB2/EphB4 pathway in postnatal angiogenesis: A potential therapeutic target for ischemic cardiovascular disease. Angiogenesis, 19, 297–309. https://doi.org/10.1007/s10456-016-9514-9
doi: 10.1007/s10456-016-9514-9
pubmed: 27216867
McIntosh, V. J., & Lasley, R. D. (2012). Adenosine receptor-mediated cardioprotection: Are all 4 subtypes required or redundant? Journal of Cardiovascular Pharmacology and Therapeutics, 17, 21–33. https://doi.org/10.1177/1074248410396877
doi: 10.1177/1074248410396877
pubmed: 21335481
Auchampach, J. A. (2007). Adenosine receptors and angiogenesis. Circulation Research, 101, 1075–1077. https://doi.org/10.1161/circresaha.107.165761
doi: 10.1161/circresaha.107.165761
pubmed: 18040023
pmcid: 2399891
Ernens, I., Bousquenaud, M., Lenoir, B., Devaux, Y., & Wagner, D. R. (2015). Adenosine stimulates angiogenesis by up-regulating production of thrombospondin-1 by macrophages. Journal of Leukocyte Biology, 97, 9–18. https://doi.org/10.1189/jlb.3HI0514-249RR
doi: 10.1189/jlb.3HI0514-249RR
pubmed: 25387836
Dehkordi, N. R., Dehkordi, N. R., & Farjoo, M. H. (2022). Therapeutic properties of stem cell-derived exosomes in ischemic heart disease. European Journal of Pharmacology, 920, 174839. https://doi.org/10.1016/j.ejphar.2022.174839
doi: 10.1016/j.ejphar.2022.174839
pubmed: 35189089
Meng, H., Cheng, W., Wang, L., Chen, S., Teng, Y., Lu, Z., Li, Y., & Zhao, M. (2021). Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: A Systematic Review of Preclinical In Vivo Studies. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-021-10168-y
doi: 10.1007/s12265-021-10168-y
pubmed: 34611844
Zhang, J., Cui, X., Guo, J., Cao, C., Zhang, Z., Wang, B., Zhang, L., Shen, D., Lim, K., Woodfield, T., Tang, J., & Zhang, J. (2020). Small but significant: Insights and new perspectives of exosomes in cardiovascular disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.15492
doi: 10.1111/jcmm.15492
pubmed: 34008309
pmcid: 7882951
Yu, X., Deng, L., Wang, D., Li, N., Chen, X., Cheng, X., Yuan, J., Gao, X., Liao, M., Wang, M., & Liao, Y. (2012). Mechanism of TNF-α autocrine effects in hypoxic cardiomyocytes: Initiated by hypoxia inducible factor 1α, presented by exosomes. Journal of Molecular and Cellular Cardiology, 53, 848–857. https://doi.org/10.1016/j.yjmcc.2012.10.002
doi: 10.1016/j.yjmcc.2012.10.002
pubmed: 23085511
Auffray, C., Fogg, D. K., Narni-Mancinelli, E., Senechal, B., Trouillet, C., Saederup, N., Leemput, J., Bigot, K., Campisi, L., Abitbol, M., Molina, T., Charo, I., Hume, D. A., Cumano, A., Lauvau, G., & Geissmann, F. (2009). CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. Journal of Experimental Medicine, 206, 595–606. https://doi.org/10.1084/jem.20081385
doi: 10.1084/jem.20081385
pubmed: 19273628
pmcid: 2699130
Cheng, W. P., Hung, H. F., Wang, B. W., & Shyu, K. G. (2008). The molecular regulation of GADD153 in apoptosis of cultured vascular smooth muscle cells by cyclic mechanical stretch. Cardiovascular Research, 77, 551–559. https://doi.org/10.1093/cvr/cvm057
doi: 10.1093/cvr/cvm057
pubmed: 18006442
Ma, Y., Mouton, A. J., & Lindsey, M. L. (2018). Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Translational Research, 191, 15–28. https://doi.org/10.1016/j.trsl.2017.10.001
doi: 10.1016/j.trsl.2017.10.001
pubmed: 29106912
Mantovani, A., Sozzani, S., Locati, M., Allavena, P., & Sica, A. (2002). Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology, 23, 549–555. https://doi.org/10.1016/s1471-4906(02)02302-5
doi: 10.1016/s1471-4906(02)02302-5
pubmed: 12401408
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S. W., & Ruhrberg, C. (2010). Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood, 116, 829–840. https://doi.org/10.1182/blood-2009-12-257832
doi: 10.1182/blood-2009-12-257832
pubmed: 20404134
pmcid: 2938310
Preston, G. A., Zarella, C. S., Pendergraft, W. F., 3rd., Rudolph, E. H., Yang, J. J., Sekura, S. B., Jennette, J. C., & Falk, R. J. (2002). Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. Journal of the American Society of Nephrology, 13, 2840–2849. https://doi.org/10.1097/01.asn.0000034911.03334.c3
doi: 10.1097/01.asn.0000034911.03334.c3
pubmed: 12444202
Silvestre, J. S., Mallat, Z., Tedgui, A., & Lévy, B. I. (2008). Post-ischaemic neovascularization and inflammation. Cardiovascular Research, 78, 242–249. https://doi.org/10.1093/cvr/cvn027
doi: 10.1093/cvr/cvn027
pubmed: 18252762
Hata, T., Takahashi, M., Hida, S., Kawaguchi, M., Kashima, Y., Usui, F., Morimoto, H., Nishiyama, A., Izawa, A., Koyama, J., Iwakura, Y., Taki, S., & Ikeda, U. (2011). Critical role of Th17 cells in inflammation and neovascularization after ischaemia. Cardiovascular Research, 90, 364–372. https://doi.org/10.1093/cvr/cvq397
doi: 10.1093/cvr/cvq397
pubmed: 21156823
Hellingman, A. A., Zwaginga, J. J., van Beem, R. T., Hamming, J. F., Fibbe, W. E., Quax, P. H., & Geutskens, S. B. (2011). T-cell-pre-stimulated monocytes promote neovascularisation in a murine hind limb ischaemia model. European Journal of Vascular and Endovascular Surgery, 41, 418–428. https://doi.org/10.1016/j.ejvs.2010.11.017
doi: 10.1016/j.ejvs.2010.11.017
pubmed: 21193337
Hur, J., Yang, H. M., Yoon, C. H., Lee, C. S., Park, K. W., Kim, J. H., Kim, T. Y., Kim, J. Y., Kang, H. J., Chae, I. H., Oh, B. H., Park, Y. B., & Kim, H. S. (2007). Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation, 116, 1671–1682. https://doi.org/10.1161/circulationaha.107.694778
doi: 10.1161/circulationaha.107.694778
pubmed: 17909106
van Weel, V., Toes, R. E., Seghers, L., Deckers, M. M., de Vries, M. R., Eilers, P. H., Sipkens, J., Schepers, A., Eefting, D., van Hinsbergh, V. W., van Bockel, J. H., & Quax, P. H. (2007). Natural killer cells and CD4+ T-cells modulate collateral artery development. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 2310–2318. https://doi.org/10.1161/atvbaha.107.151407
doi: 10.1161/atvbaha.107.151407
pubmed: 17717295
Bouchentouf, M., Forner, K. A., Cuerquis, J., Michaud, V., Zheng, J., Paradis, P., Schiffrin, E. L., & Galipeau, J. (2010). Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells. The Journal of Immunology, 185, 7014–7025. https://doi.org/10.4049/jimmunol.1001888
doi: 10.4049/jimmunol.1001888
pubmed: 20971926
Zouggari, Y., Ait-Oufella, H., Waeckel, L., Vilar, J., Loinard, C., Cochain, C., Récalde, A., Duriez, M., Levy, B. I., Lutgens, E., Mallat, Z., & Silvestre, J. S. (2009). Regulatory T cells modulate postischemic neovascularization. Circulation, 120, 1415–1425. https://doi.org/10.1161/circulationaha.109.875583
doi: 10.1161/circulationaha.109.875583
pubmed: 19770391
Hellingman, A. A., van der Vlugt, L. E., Lijkwan, M. A., Bastiaansen, A. J., Sparwasser, T., Smits, H. H., Hamming, J. F., & Quax, P. H. (2012). A limited role for regulatory T cells in post-ischemic neovascularization. Journal of Cellular and Molecular Medicine, 16, 328–336. https://doi.org/10.1111/j.1582-4934.2011.01300.x
doi: 10.1111/j.1582-4934.2011.01300.x
pubmed: 21426486
pmcid: 3823296
Feoktistov, I., Ryzhov, S., Goldstein, A. E., & Biaggioni, I. (2003). Mast cell-mediated stimulation of angiogenesis: Cooperative interaction between A2B and A3 adenosine receptors. Circulation Research, 92, 485–492. https://doi.org/10.1161/01.res.0000061572.10929.2d
doi: 10.1161/01.res.0000061572.10929.2d
pubmed: 12600879
Somasundaram, P., Ren, G., Nagar, H., Kraemer, D., Mendoza, L., Michael, L. H., Caughey, G. H., Entman, M. L., & Frangogiannis, N. G. (2005). Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. The Journal of Pathology, 205, 102–111. https://doi.org/10.1002/path.1690
doi: 10.1002/path.1690
pubmed: 15586361
Prasad, M., Corban, M. T., Henry, T. D., Dietz, A. B., Lerman, L. O., & Lerman, A. (2020). Promise of Autologous CD34+ Stem/Progenitor Cell Therapy for Treatment of Cardiovascular Disease. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaa027
doi: 10.1093/cvr/cvaa027
pubmed: 32022845
Aikawa, T., Naya, M., Koyanagawa, K., Manabe, O., Obara, M., Magota, K., Oyama-Manabe, N., Tamaki, N., & Anzai, T. (2020). Improved regional myocardial blood flow and flow reserve after coronary revascularization as assessed by serial 15O-water positron emission tomography/computed tomography. European Heart Journal Cardiovascular Imaging, 21, 36–46. https://doi.org/10.1093/ehjci/jez220
doi: 10.1093/ehjci/jez220
pubmed: 31544927
Maaniitty, T., Jaakkola, S., Saraste, A., & Knuuti, J. (2019). Hybrid coronary computed tomography angiography and positron emission tomography myocardial perfusion imaging in evaluation of recurrent symptoms after coronary artery bypass grafting. European Heart Journal Cardiovascular Imaging, 20, 1298–1304. https://doi.org/10.1093/ehjci/jey160
doi: 10.1093/ehjci/jey160
pubmed: 30388202
Balogh, V., MacAskill, M. G., Hadoke, P. W. F., Gray, G. A., & Tavares, A. A. S. (2021). Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure. Front Cardiovasc Med, 8, 719031. https://doi.org/10.3389/fcvm.2021.719031
doi: 10.3389/fcvm.2021.719031
pubmed: 34485416
pmcid: 8416043
Jenkins, W. S., Vesey, A. T., Stirrat, C., Connell, M., Lucatelli, C., Neale, A., Moles, C., Vickers, A., Fletcher, A., Pawade, T., Wilson, I., Rudd, J. H., van Beek, E. J., Mirsadraee, S., Dweck, M. R., & Newby, D. E. (2017). Cardiac alphaVbeta3 integrin expression following acute myocardial infarction in humans. Heart, 103, 607–615. https://doi.org/10.1136/heartjnl-2016-310115
doi: 10.1136/heartjnl-2016-310115
pubmed: 27927700
Ferguson, T. B., Jr. (2016). Physiology of in-situ arterial revascularization in coronary artery bypass grafting: Preoperative, intraoperative and postoperative factors and influences. World Journal of Cardiology, 8, 623–637. https://doi.org/10.4330/wjc.v8.i11.623
doi: 10.4330/wjc.v8.i11.623
pubmed: 27957249
Ferguson, T. B., Jr., Chen, C., Babb, J. D., Efird, J. T., Daggubati, R., & Cahill, J. M. (2013). Fractional flow reserve-guided coronary artery bypass grafting: Can intraoperative physiologic imaging guide decision making? Journal of Thoracic and Cardiovascular Surgery, 146, 824-835.e821. https://doi.org/10.1016/j.jtcvs.2013.06.026
doi: 10.1016/j.jtcvs.2013.06.026
pubmed: 23915918
Ferguson, T. B., Jr., Chen, C., & Buch, A. N. (2013). Fractional flow reserve-guided coronary bypass surgery: Should surgeons use it? Current Opinion in Cardiology, 28, 654–660. https://doi.org/10.1097/HCO.0b013e32836581a3
doi: 10.1097/HCO.0b013e32836581a3
pubmed: 24100651
Shimizu, T., Ito, S., Kikuchi, Y., Misaka, M., Hirayama, T., Ishimaru, S., & Yamashina, A. (2004). Arterial conduit shear stress following bypass grafting for intermediate coronary artery stenosis: A comparative study with saphenous vein grafts. European Journal of Cardio-Thoracic Surgery, 25, 578–584. https://doi.org/10.1016/j.ejcts.2003.12.039
doi: 10.1016/j.ejcts.2003.12.039
pubmed: 15037275
Davies, P. F. (2009). Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nature Clinical Practice. Cardiovascular Medicine, 6, 16–26. https://doi.org/10.1038/ncpcardio1397
doi: 10.1038/ncpcardio1397
pubmed: 19029993
Gutterman, D. D., Chabowski, D. S., Kadlec, A. O., Durand, M. J., Freed, J. K., Ait-Aissa, K., & Beyer, A. M. (2016). The Human Microcirculation: Regulation of Flow and Beyond. Circulation Research, 118, 157–172. https://doi.org/10.1161/circresaha.115.305364
doi: 10.1161/circresaha.115.305364
pubmed: 26837746
pmcid: 4742348
Akasaka, T., Yoshikawa, J., Yoshida, K., Maeda, K., Hozumi, T., Nasu, M., & Shomura, T. (1995). Flow capacity of internal mammary artery grafts: Early restriction and later improvement assessed by Doppler guide wire. Comparison with saphenous vein grafts. Journal of the American College of Cardiology, 25, 640–647. https://doi.org/10.1016/0735-1097(94)00448-y
doi: 10.1016/0735-1097(94)00448-y
pubmed: 7860908
Hartman, J., Kelder, H., Ackerstaff, R., van Swieten, H., Vermeulen, F., & Bogers, A. (2007). Preserved hyperaemic response in (distal) string sign left internal mammary artery grafts. European Journal of Cardio-Thoracic Surgery, 31, 283–289. https://doi.org/10.1016/j.ejcts.2006.11.016
doi: 10.1016/j.ejcts.2006.11.016
pubmed: 17161609
Spadaccio, C., Nappi, F., Al-Attar, N., Coccia, R., Perluigi, M., & Di Domenico, F. (2016). CURRENT DEVELOPMENTS IN DRUG ELUTING DEVICES: Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis. Drug Target Insights, 10, 15–19. https://doi.org/10.4137/DTI.S41240
doi: 10.4137/DTI.S41240
pubmed: 28096649
Wang, Y., Gabrielsen, A., Lawler, P. R., Paulsson-Berne, G., Steinbrüchel, D. A., Hansson, G. K., & Kastrup, J. (2006). Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: Influence of acute ischemia/cardioplegia and reperfusion. Microcirculation, 13, 187–197. https://doi.org/10.1080/10739680600556811
doi: 10.1080/10739680600556811
pubmed: 16627361
Ramos, C., Napoleao, P., Selas, M., Freixo, C., Viegas Crespo, A. M., Mota Carmo, M., Cruz Ferreira, R., & Pinheiro, T. (2014). Prognostic value of VEGF in patients submitted to percutaneous coronary intervention. Disease Markers, 2014, 135357. https://doi.org/10.1155/2014/135357
doi: 10.1155/2014/135357
pubmed: 25110384
pmcid: 4109329
Cotton, J. M., Mathur, A., Hong, Y., Brown, A. S., Martin, J. F., & Erusalimsky, J. D. (2002). Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. European Heart Journal, 23, 953–959. https://doi.org/10.1053/euhj.2001.3034
doi: 10.1053/euhj.2001.3034
pubmed: 12069450
Han X, Liu L, Niu J, Yang J, Zhang Z, Zhang Z (2015) Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy. Med Sci Monit 21:3247–3251. https://doi.org/10.12659/msm.894803
Denizot, Y., Leguyader, A., Cornu, E., Laskar, M., Orsel, I., Vincent, C., & Nathan, N. (2008). Alterations in plasma soluble vascular endothelial growth factor receptor-1 (sFlt-1) concentrations during coronary artery bypass graft surgery: Relationships with post-operative complications. Journal of Cardiothoracic Surgery, 3, 16. https://doi.org/10.1186/1749-8090-3-16
doi: 10.1186/1749-8090-3-16
pubmed: 18423019
pmcid: 2365942
Dai, R., Liu, Y., Zhou, Y., Xiong, X., Zhou, W., Li, W., Zhou, W., & Chen, M. (2020). Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention. Journal of Clinical Laboratory Analysis, 34, e23013. https://doi.org/10.1002/jcla.23013
doi: 10.1002/jcla.23013
pubmed: 31495986
Tarr, F. I., Sasvari, M., Tarr, M., & Racz, R. (2005). Evidence of nitric oxide produced by the internal mammary artery graft in venous drainage of the recipient coronary artery. Annals of Thoracic Surgery, 80, 1728–1731. https://doi.org/10.1016/j.athoracsur.2005.05.005
doi: 10.1016/j.athoracsur.2005.05.005
pubmed: 16242446
Tarr, F., Dudas, G., Tarr, M., Racz, R., Sasvari, M., & Tomcsanyi, I. (2002). Analysis of the stable metabolite of endothelium-derived nitric oxide of internal mammary artery bypass grafts at the venous drainage system of the recipient coronary artery. Morphologic implications and consequences. Orvosi Hetilap, 143, 2549–2552.
pubmed: 12501561
Liu ZG, Ge ZD, He GW (2000) Difference in endothelium-derived hyperpolarizing factor-mediated hyperpolarization and nitric oxide release between human internal mammary artery and saphenous vein. Circulation 102:Iii296–301. https://doi.org/10.1161/01.cir.102.suppl_3.iii-296
Fonseca, D. A., Antunes, P. E., Antunes, M. J., & Cotrim, M. D. (2019). Histomorphometric analysis of the human internal thoracic artery and relationship with cardiovascular risk factors. PLoS ONE, 14, e0211421. https://doi.org/10.1371/journal.pone.0211421
doi: 10.1371/journal.pone.0211421
pubmed: 30682154
pmcid: 6347214
MJ Nawrocki B Perek P Sujka-Kordowska A Konwerska S Kaluzna P Zawierucha M Bruska M Zabel M Jemielity M Nowicki B Kempisty A Malinska 2019 Differences in Expression of Genes Involved in Bone Development and Morphogenesis in the Walls of Internal Thoracic Artery and Saphenous Vein Conduits May Provide Markers Useful for Evaluation Graft Patency International Journal of Molecular Sciences 20. https://doi.org/10.3390/ijms20194890
Veres, G., Schmidt, H., Hegedus, P., Korkmaz-Icoz, S., Radovits, T., Loganathan, S., Brlecic, P., Li, S., Karck, M., & Szabo, G. (2018). Is internal thoracic artery resistant to reperfusion injury? Evaluation of the storage of free internal thoracic artery grafts. Journal of Thoracic and Cardiovascular Surgery, 156, 1460–1469. https://doi.org/10.1016/j.jtcvs.2018.05.079
doi: 10.1016/j.jtcvs.2018.05.079
pubmed: 30257283
Podemska-Jedrzejczak, Z., Malinska, A., Sujka-Kordowska, P., Nowicki, M., Puslecki, M., Jemielity, M., & Perek, B. (2018). Vascular restenosis in coronary artery bypass grafting might be associated with VEGF-C/VEGFR-3 signaling pathway. Heart and Vessels, 33, 1106–1120. https://doi.org/10.1007/s00380-018-1158-9
doi: 10.1007/s00380-018-1158-9
pubmed: 29557990
Alattar, M., Jiang, C., Luan, Z., Pan, T., Liu, L., & Li, J. (2014). Neuropilin 1 expression in human aortas, coronaries and the main bypass grafts. European Journal of Cardio-Thoracic Surgery, 46, 967–973. https://doi.org/10.1093/ejcts/ezu118
doi: 10.1093/ejcts/ezu118
pubmed: 24722942
de la Cuesta, F., Alvarez-Llamas, G., Maroto, A. S., Donado, A., Zubiri, I., Posada, M., Padial, L. R., Pinto, A. G., Barderas, M. G., & Vivanco, F. (2011). A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Molecular and Cellular Proteomics, 10(M110), 003517. https://doi.org/10.1074/mcp.M110.003517
doi: 10.1074/mcp.M110.003517
pubmed: 21248247
Lyck Hansen, M., Beck, H. C., Irmukhamedov, A., Jensen, P. S., Olsen, M. H., & Rasmussen, L. M. (2015). Proteome analysis of human arterial tissue discloses associations between the vascular content of small leucine-rich repeat proteoglycans and pulse wave velocity. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 1896–1903. https://doi.org/10.1161/ATVBAHA.114.304706
doi: 10.1161/ATVBAHA.114.304706
pubmed: 26069235
Numaguchi, R., Furuhashi, M., Matsumoto, M., Sato, H., Yanase, Y., Kuroda, Y., Harada, R., Ito, T., Higashiura, Y., Koyama, M., Tanaka, M., Moniwa, N., Nakamura, M., Doi, H., Miura, T., & Kawaharada, N. (2019). Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery. Journal of the American Heart Association, 8, e011147. https://doi.org/10.1161/JAHA.118.011147
doi: 10.1161/JAHA.118.011147
pubmed: 30638109
pmcid: 6497339
Loukas, M., Hanna, M., Chen, J., Tubbs, R. S., & Anderson, R. H. (2011). Extracardiac coronary arterial anastomoses. Clinical Anatomy, 24, 137–142. https://doi.org/10.1002/ca.21088
doi: 10.1002/ca.21088
pubmed: 21322035
MR Bigler C Seiler 2019 The Human Coronary Collateral Circulation, Its Extracardiac Anastomoses and Their Therapeutic Promotion International Journal of Molecular Sciences 20. https://doi.org/10.3390/ijms20153726
Piciche, M., & Versaci, F. (2020). Neoangiogenesis connecting a left internal mammary artery proximal stump to an ischemic area of the heart after bypass occlusion. Journal of Cardiac Surgery, 35, 464–466. https://doi.org/10.1111/jocs.14353
doi: 10.1111/jocs.14353
pubmed: 31730738
Redd, M. A., Zeinstra, N., Qin, W., Wei, W., Martinson, A., Wang, Y., Wang, R. K., Murry, C. E., & Zheng, Y. (2019). Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts. Nature Communications, 10, 584. https://doi.org/10.1038/s41467-019-08388-7
doi: 10.1038/s41467-019-08388-7
pubmed: 30718840
pmcid: 6362250
Cobb, L. A., Thomas, G. I., Dillard, D. H., Merendino, K. A., & Bruce, R. A. (1959). An evaluation of internal-mammary-artery ligation by a double-blind technic. New England Journal of Medicine, 260, 1115–1118. https://doi.org/10.1056/NEJM195905282602204
doi: 10.1056/NEJM195905282602204
pubmed: 13657350
Kitchell, J. R., Glover, R. P., & Kyle, R. H. (1958). Bilateral internal mammary artery ligation for angina pectoris. The American Journal of Cardiology, 1, 46–50. https://doi.org/10.1016/0002-9149(58)90074-2
doi: 10.1016/0002-9149(58)90074-2
pubmed: 13497954
Stoller, M., de Marchi, S. F., & Seiler, C. (2014). Function of natural internal mammary-to-coronary artery bypasses and its effect on myocardial ischemia. Circulation, 129, 2645–2652. https://doi.org/10.1161/CIRCULATIONAHA.114.008898
doi: 10.1161/CIRCULATIONAHA.114.008898
pubmed: 24744276
M Stoller C Seiler 2017 Effect of Permanent Right Internal Mammary Artery Closure on Coronary Collateral Function and Myocardial Ischemia Circulation. Cardiovascular Interventions 10. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004990
Tatoulis, J., Buxton, B. F., & Fuller, J. A. (2004). Patencies of 2127 arterial to coronary conduits over 15 years. Annals of Thoracic Surgery, 77, 93–101. https://doi.org/10.1016/s0003-4975(03)01331-6
doi: 10.1016/s0003-4975(03)01331-6
pubmed: 14726042
Li, G., Zhang, Y., Wu, Z., Liu, Z., & Zheng, J. (2019). Mid-term and long-term outcomes of endoscopic versus open vein harvesting for coronary artery bypass: A systematic review and meta-analysis. International Journal of Surgery, 72, 167–173. https://doi.org/10.1016/j.ijsu.2019.11.003
doi: 10.1016/j.ijsu.2019.11.003
pubmed: 31707009
Gaba, P., Gersh, B. J., Ali, Z. A., Moses, J. W., & Stone, G. W. (2021). Complete versus incomplete coronary revascularization: Definitions, assessment and outcomes. Nature Reviews. Cardiology, 18, 155–168. https://doi.org/10.1038/s41569-020-00457-5
doi: 10.1038/s41569-020-00457-5
pubmed: 33067581
Benedetto, U., Gaudino, M., Di Franco, A., Caputo, M., Ohmes, L. B., Grau, J., Glineur, D., Girardi, L. N., & Angelini, G. D. (2018). Incomplete revascularization and long-term survival after coronary artery bypass surgery. International Journal of Cardiology, 254, 59–63. https://doi.org/10.1016/j.ijcard.2017.08.005
doi: 10.1016/j.ijcard.2017.08.005
pubmed: 29407133
Hattler B, Grover FL, Wagner T, Hawkins RB, Quin JA, Collins JF, Bishawi M, Almassi H, Shroyer AL, Veterans Affairs Randomized On/Off Bypass Follow-up Study G. (2020). Incidence and Prognostic Impact of Incomplete Revascularization Documented by Coronary Angiography 1 Year After Coronary Artery Bypass Grafting. American Journal of Cardiology, 131, 7–11. https://doi.org/10.1016/j.amjcard.2020.06.047
doi: 10.1016/j.amjcard.2020.06.047
Schaefer, A., Conradi, L., Schneeberger, Y., Reichenspurner, H., Sandner, S., Tebbe, U., Nowak, B., Stritzke, J., Kastrati, A., Schunkert, H., von Scheidt, M., & Ti CABi,. (2020). Clinical outcomes of complete versus incomplete revascularization in patients treated with coronary artery bypass grafting: Insights from the TiCAB trial. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaa330
doi: 10.1093/ejcts/ezaa330
pubmed: 33188598
Milojevic, M., Head, S. J., Parasca, C. A., Serruys, P. W., Mohr, F. W., Morice, M. C., Mack, M. J., Stahle, E., Feldman, T. E., Dawkins, K. D., Colombo, A., Kappetein, A. P., & Holmes, D. R., Jr. (2016). Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX. Journal of the American College of Cardiology, 67, 42–55. https://doi.org/10.1016/j.jacc.2015.10.043
doi: 10.1016/j.jacc.2015.10.043
pubmed: 26764065
Takahashi, K., Serruys, P. W., Gao, C., Ono, M., Wang, R., Thuijs, D., Mack, M. J., Curzen, N., Mohr, F. W., Davierwala, P., Milojevic, M., Wykrzykowska, J. J., de Winter, R. J., Sharif, F., Onuma, Y., Head, S. J., Kappetein, A. P., Morice, M. C., Holmes, D. R., Jr., & Investigators, S. E. S. S. (2021). Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study. Circulation, 144, 96–109. https://doi.org/10.1161/CIRCULATIONAHA.120.046289
doi: 10.1161/CIRCULATIONAHA.120.046289
pubmed: 34011163
Bangalore, S., Guo, Y., Samadashvili, Z., & Hannan, E. L. (2020). Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents. American Journal of Cardiology, 125, 362–369. https://doi.org/10.1016/j.amjcard.2019.10.022
doi: 10.1016/j.amjcard.2019.10.022
pubmed: 31810515
Kim, Y. H., Her, A. Y., Jeong, M. H., Kim, B. K., Hong, S. J., Kim, S., Ahn, C. M., Kim, J. S., Ko, Y. G., Choi, D., Hong, M. K., & Jang, Y. (2020). Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents. Atherosclerosis, 301, 54–64. https://doi.org/10.1016/j.atherosclerosis.2020.04.002
doi: 10.1016/j.atherosclerosis.2020.04.002
pubmed: 32330691
Head, S. J., Mack, M. J., Holmes, D. R., Jr., Mohr, F. W., Morice, M. C., Serruys, P. W., & Kappetein, A. P. (2012). Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: A subgroup analysis of 3-year SYNTAX data. European Journal of Cardio-Thoracic Surgery, 41, 535–541. https://doi.org/10.1093/ejcts/ezr105
doi: 10.1093/ejcts/ezr105
pubmed: 22219412
Spadaccio C, Nenna A, Nappi F, Barbato R, Greco SM, Nusca A, Sommariva L, Chello M (2018) Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study. J Geriatr Cardiol 15:479–485. https://doi.org/10.11909/j.issn.1671-5411.2018.07.003
Head, S. J., Milojevic, M., Daemen, J., Ahn, J. M., Boersma, E., Christiansen, E. H., Domanski, M. J., Farkouh, M. E., Flather, M., Fuster, V., Hlatky, M. A., Holm, N. R., Hueb, W. A., Kamalesh, M., Kim, Y. H., Makikallio, T., Mohr, F. W., Papageorgiou, G., Park, S. J., … Kappetein, A. P. (2018). Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data. Lancet, 391, 939–948. https://doi.org/10.1016/s0140-6736(18)30423-9
doi: 10.1016/s0140-6736(18)30423-9
pubmed: 29478841
Watanabe, N., Yonekura, S., Williams, A. G., Jr., Scheel, K. W., & Downey, H. F. (1989). Regression and recovery of well-developed coronary collateral function in canine hearts after aorta-coronary bypass. Journal of Thoracic and Cardiovascular Surgery, 97, 286–296.
doi: 10.1016/S0022-5223(19)35337-1
pubmed: 2492626
Zimarino, M., Ausiello, A., Contegiacomo, G., Riccardi, I., Renda, G., Di Iorio, C., & De Caterina, R. (2006). Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: The trade-off of successful percutaneous recanalization of chronic total occlusions. Journal of the American College of Cardiology, 48, 59–65. https://doi.org/10.1016/j.jacc.2005.12.079
doi: 10.1016/j.jacc.2005.12.079
pubmed: 16814649
Pereg, D., Fefer, P., Samuel, M., Wolff, R., Czarnecki, A., Deb, S., Sparkes, J. D., Fremes, S. E., & Strauss, B. H. (2014). Native coronary artery patency after coronary artery bypass surgery. JACC. Cardiovascular Interventions, 7, 761–767. https://doi.org/10.1016/j.jcin.2014.01.164
doi: 10.1016/j.jcin.2014.01.164
pubmed: 25060019
Caputo, M., Anis, R. R., Rogers, C. A., Ahmad, N., Rizvi, S. I., Baumbach, A., Karsch, K. R., Angelini, G. D., & Oberhoff, M. (2008). Coronary collateral circulation: Effect on early and midterm outcomes after off-pump coronary artery bypass surgery. Annals of Thoracic Surgery, 85, 71–79. https://doi.org/10.1016/j.athoracsur.2007.08.026
doi: 10.1016/j.athoracsur.2007.08.026
pubmed: 18154783
Nathoe, H. M., Buskens, E., Jansen, E. W., Suyker, W. J., Stella, P. R., Lahpor, J. R., van Boven, W. J., van Dijk, D., Diephuis, J. C., Borst, C., Moons, K. G., Grobbee, D. E., & de Jaegere, P. P. (2004). Role of coronary collaterals in off-pump and on-pump coronary bypass surgery. Circulation, 110, 1738–1742. https://doi.org/10.1161/01.cir.0000143105.42988.fd
doi: 10.1161/01.cir.0000143105.42988.fd
pubmed: 15381650
Kaku, D., Nakahira, A., Hirai, H., Sasaki, Y., Hosono, M., Bito, Y., Suehiro, Y., & Suehiro, S. (2013). Does rich coronary collateral circulation distal to chronically occluded left anterior descending artery compete with graft flow? Interactive Cardiovascular and Thoracic Surgery, 17, 944–949. https://doi.org/10.1093/icvts/ivt337
doi: 10.1093/icvts/ivt337
pubmed: 23959772
pmcid: 3829484
Oshima, H., Tokuda, Y., Araki, Y., Ishii, H., Murohara, T., Ozaki, Y., & Usui, A. (2016). Predictors of early graft failure after coronary artery bypass grafting for chronic total occlusion. Interactive Cardiovascular and Thoracic Surgery, 23, 142–149. https://doi.org/10.1093/icvts/ivw084
doi: 10.1093/icvts/ivw084
pubmed: 27030683
pmcid: 4986749
Takami, Y., & Masumoto, H. (2007). Angiographic fate of collateral vessels after surgical revascularization of the totally occluded left anterior descending artery. Annals of Thoracic Surgery, 83, 120–125. https://doi.org/10.1016/j.athoracsur.2006.08.033
doi: 10.1016/j.athoracsur.2006.08.033
pubmed: 17184642
Nusca, A., & Patti, G. (2012). Platelet function and inhibition in ischemic heart disease. Current Cardiology Reports, 14, 457–467. https://doi.org/10.1007/s11886-012-0280-z
doi: 10.1007/s11886-012-0280-z
pubmed: 22562594
Bi, W., Wang, J., Jiang, Y., Li, Q., Wang, S., Liu, M., Liu, Q., Li, F., Paul, C., Wang, Y., & Yang, H. T. (2021). Neurotrophin-3 contributes to benefits of human embryonic stem cell-derived cardiovascular progenitor cells against reperfused myocardial infarction. Stem Cells Translational Medicine, 10, 756–772. https://doi.org/10.1002/sctm.20-0456
doi: 10.1002/sctm.20-0456
pubmed: 33529481
pmcid: 8046156
Gladka, M. M., Kohela, A., Molenaar, B., Versteeg, D., Kooijman, L., Monshouwer-Kloots, J., Kremer, V., Vos, H. R., Huibers, M. M. H., Haigh, J. J., Huylebroeck, D., Boon, R. A., Giacca, M., & van Rooij, E. (2021). Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nature Communications, 12, 84. https://doi.org/10.1038/s41467-020-20361-3
doi: 10.1038/s41467-020-20361-3
pubmed: 33398012
pmcid: 7782784
M Sabra C Karbasiafshar A Aboulgheit S Raj MR Abid FW Sellke 2021 Clinical Application of Novel Therapies for Coronary Angiogenesis: Overview, Challenges, and Prospects International Journal of Molecular Sciences 22. https://doi.org/10.3390/ijms22073722
Eelen, G., Treps, L., Li, X., & Carmeliet, P. (2020). Basic and Therapeutic Aspects of Angiogenesis Updated. Circulation Research, 127, 310–329. https://doi.org/10.1161/CIRCRESAHA.120.316851
doi: 10.1161/CIRCRESAHA.120.316851
pubmed: 32833569
Henning, R. J. (2021). Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology. Journal of Cardiovascular Translational Research, 14, 195–212. https://doi.org/10.1007/s12265-020-10040-5
doi: 10.1007/s12265-020-10040-5
pubmed: 32588374
Kesidou, D., da Costa Martins, P. A., de Windt, L. J., Brittan, M., Beqqali, A., & Baker, A. H. (2020). Extracellular Vesicle miRNAs in the Promotion of Cardiac Neovascularisation. Frontiers in Physiology, 11, 579892. https://doi.org/10.3389/fphys.2020.579892
doi: 10.3389/fphys.2020.579892
pubmed: 33101061
pmcid: 7546892
Moghiman, T., Barghchi, B., Esmaeili, S. A., Shabestari, M. M., Tabaee, S. S., & Momtazi-Borojeni, A. A. (2021). Therapeutic angiogenesis with exosomal microRNAs: An effectual approach for the treatment of myocardial ischemia. Heart Failure Reviews, 26, 205–213. https://doi.org/10.1007/s10741-020-10001-9
doi: 10.1007/s10741-020-10001-9
pubmed: 32632768
R Kwast van der PHA Quax AY Nossent 2019 An Emerging Role for isomiRs and the microRNA Epitranscriptome in Neovascularization Cells 9. https://doi.org/10.3390/cells9010061
Zhang, T. R., & Huang, W. Q. (2021). Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease. Journal of Cardiovascular Translational Research, 14, 824–840. https://doi.org/10.1007/s12265-020-10082-9
doi: 10.1007/s12265-020-10082-9
pubmed: 33104961
Lu, W., Sheng, Z., Zhang, Z., Ma, G., Chen, L., Huang, J., Ding, J., & Dai, Q. (2020). LncRNA-LUNAR1 Levels Are Closely Related to Coronary Collaterals in Patients with Chronic Total Coronary Occlusion. Journal of Cardiovascular Translational Research, 13, 171–180. https://doi.org/10.1007/s12265-019-09917-x
doi: 10.1007/s12265-019-09917-x
pubmed: 31997261
Huang, M., Zheng, J., Chen, Z., You, C., & Huang, Q. (2020). The Relationship Between Circulating Neuregulin-1 and Coronary Collateral Circulation in Patients with Coronary Artery Disease. International Heart Journal, 61, 115–120. https://doi.org/10.1536/ihj.19-277
doi: 10.1536/ihj.19-277
pubmed: 31956140
Molin, D., & Post, M. J. (2007). Therapeutic angiogenesis in the heart: Protect and serve. Current Opinion in Pharmacology, 7, 158–163. https://doi.org/10.1016/j.coph.2006.10.006
doi: 10.1016/j.coph.2006.10.006
pubmed: 17284359
Komai, Y., Nakano, A., & Niimi, H. (2005). Capillary angiogenesis and remodeling induced in rat limb by arteriovenous shunting. Clinical Hemorheology and Microcirculation, 32, 199–208.
pubmed: 15851839
Rosenblum, J. M., Binongo, J., Wei, J., Liu, Y., Leshnower, B. G., Chen, E. P., Miller, J. S., Macheers, S. K., Lattouf, O. M., Guyton, R. A., Thourani, V. H., Halkos, M. E., & Keeling, W. B. (2021). Priorities in coronary artery bypass grafting: Is midterm survival more dependent on completeness of revascularization or multiple arterial grafts? Journal of Thoracic and Cardiovascular Surgery, 161(2070–2078), e2076. https://doi.org/10.1016/j.jtcvs.2019.11.125
doi: 10.1016/j.jtcvs.2019.11.125
Wang, G. L., & Semenza, G. L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood, 82, 3610–3615.
doi: 10.1182/blood.V82.12.3610.3610
pubmed: 8260699
Kaelin, W. G., Jr., & Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Molecular Cell, 30, 393–402. https://doi.org/10.1016/j.molcel.2008.04.009
doi: 10.1016/j.molcel.2008.04.009
pubmed: 18498744
Chang, E. I., Loh, S. A., Ceradini, D. J., Chang, E. I., Lin, S. E., Bastidas, N., Aarabi, S., Chan, D. A., Freedman, M. L., Giaccia, A. J., & Gurtner, G. C. (2007). Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation, 116, 2818–2829. https://doi.org/10.1161/circulationaha.107.715847
doi: 10.1161/circulationaha.107.715847
pubmed: 18040029
Liu, Y., Zou, J., Liu, X., & Zhang, Q. (2019). MicroRNA-138 attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis by targeting HIF1-alpha. Experimental and Therapeutic Medicine, 18, 3325–3332. https://doi.org/10.3892/etm.2019.7976
doi: 10.3892/etm.2019.7976
pubmed: 31602205
pmcid: 6777330
Ho, Y. T., Poinard, B., & Kah, J. C. (2016). Nanoparticle drug delivery systems and their use in cardiac tissue therapy. Nanomedicine (London, England), 11, 693–714. https://doi.org/10.2217/nnm.16.6
doi: 10.2217/nnm.16.6
Rodness, J., Mihic, A., Miyagi, Y., Wu, J., Weisel, R. D., & Li, R. K. (2016). VEGF-loaded microsphere patch for local protein delivery to the ischemic heart. Acta Biomaterialia, 45, 169–181. https://doi.org/10.1016/j.actbio.2016.09.009
doi: 10.1016/j.actbio.2016.09.009
pubmed: 27619839
Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., Gibson, C. M., Bajamonde, A., Rundle, A. C., Fine, J., & McCluskey, E. R. (2003). The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation, 107, 1359–1365. https://doi.org/10.1161/01.cir.0000061911.47710.8a
doi: 10.1161/01.cir.0000061911.47710.8a
pubmed: 12642354
Simon-Yarza, T., Tamayo, E., Benavides, C., Lana, H., Formiga, F. R., Grama, C. N., Ortiz-de-Solorzano, C., Kumar, M. N., Prosper, F., & Blanco-Prieto, M. J. (2013). Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia. International Journal of Pharmaceutics, 454, 784–790. https://doi.org/10.1016/j.ijpharm.2013.04.015
doi: 10.1016/j.ijpharm.2013.04.015
pubmed: 23639291
Oduk, Y., Zhu, W., Kannappan, R., Zhao, M., Borovjagin, A. V., Oparil, S., & Zhang, J. J. (2018). VEGF nanoparticles repair the heart after myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology, 314, H278-h284. https://doi.org/10.1152/ajpheart.00471.2017
doi: 10.1152/ajpheart.00471.2017
pubmed: 29101176
Thirunavukkarasu, M., Selvaraju, V., Joshi, M., Coca-Soliz, V., Tapias, L., Saad, I., Fournier, C., Husain, A., Campbell, J., Yee, S. P., Sanchez, J. A., Palesty, J. A., McFadden, D. W., & Maulik, N. (2018). Disruption of VEGF Mediated Flk-1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino-1. Journal of the American Heart Association, 7, e007601. https://doi.org/10.1161/jaha.117.007601
doi: 10.1161/jaha.117.007601
pubmed: 30371196
pmcid: 6222946
Calvert, J. W., Jha, S., Gundewar, S., Elrod, J. W., Ramachandran, A., Pattillo, C. B., Kevil, C. G., & Lefer, D. J. (2009). Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circulation Research, 105, 365–374. https://doi.org/10.1161/circresaha.109.199919
doi: 10.1161/circresaha.109.199919
pubmed: 19608979
pmcid: 2735849
Ling, K., Xu, A., Chen, Y., Chen, X., Li, Y., & Wang, W. (2019). Protective effect of a hydrogen sulfide donor on balloon injury-induced restenosis via the Nrf2/HIF-1alpha signaling pathway. International Journal of Molecular Medicine, 43, 1299–1310. https://doi.org/10.3892/ijmm.2019.4076
doi: 10.3892/ijmm.2019.4076
pubmed: 30747216
pmcid: 6365080
Kan, J., Guo, W., Huang, C., Bao, G., Zhu, Y., & Zhu, Y. Z. (2014). S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. Antioxidants & Redox Signaling, 20, 2303–2316. https://doi.org/10.1089/ars.2013.5449
doi: 10.1089/ars.2013.5449
Osugi, T., Oshima, Y., Fujio, Y., Funamoto, M., Yamashita, A., Negoro, S., Kunisada, K., Izumi, M., Nakaoka, Y., Hirota, H., Okabe, M., Yamauchi-Takihara, K., Kawase, I., & Kishimoto, T. (2002). Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. Journal of Biological Chemistry, 277, 6676–6681. https://doi.org/10.1074/jbc.M108246200
doi: 10.1074/jbc.M108246200
pubmed: 11744720
G Hutchings K Janowicz L Moncrieff C Dompe E Strauss I Kocherova MJ Nawrocki L Kruszyna G Wasiatycz P Antosik JA Shibli P Mozdziak B Perek Z Krasinski B Kempisty M Nowicki 2020 The Proliferation and Differentiation of Adipose-Derived Stem Cells in Neovascularization and Angiogenesis International Journal of Molecular Sciences 21. https://doi.org/10.3390/ijms21113790
Valina, C., Pinkernell, K., Song, Y. H., Bai, X., Sadat, S., Campeau, R. J., Le Jemtel, T. H., & Alt, E. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28, 2667–2677. https://doi.org/10.1093/eurheartj/ehm426
doi: 10.1093/eurheartj/ehm426
pubmed: 17933755
Wang, L., Deng, J., Tian, W., Xiang, B., Yang, T., Li, G., Wang, J., Gruwel, M., Kashour, T., Rendell, J., Glogowski, M., Tomanek, B., Freed, D., Deslauriers, R., Arora, R. C., & Tian, G. (2009). Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: An MR imaging study of rat hearts. American Journal of Physiology. Heart and Circulatory Physiology, 297, H1020-1031. https://doi.org/10.1152/ajpheart.01082.2008
doi: 10.1152/ajpheart.01082.2008
pubmed: 19574490
Zhao, L., Johnson, T., & Liu, D. (2017). Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases. Stem Cell Research & Therapy, 8, 125. https://doi.org/10.1186/s13287-017-0578-2
doi: 10.1186/s13287-017-0578-2
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 85, 221–228. https://doi.org/10.1161/01.res.85.3.221
doi: 10.1161/01.res.85.3.221
pubmed: 10436164
Minami, Y., Nakajima, T., Ikutomi, M., Morita, T., Komuro, I., Sata, M., & Sahara, M. (2015). Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence. International Journal of Cardiology, 186, 305–314. https://doi.org/10.1016/j.ijcard.2015.03.166
doi: 10.1016/j.ijcard.2015.03.166
pubmed: 25838182
Sukmawati, D., & Tanaka, R. (2015). Introduction to next generation of endothelial progenitor cell therapy: A promise in vascular medicine. Am J Transl Res, 7, 411–421.
pubmed: 26045883
pmcid: 4448183
Steinle, H., Golombek, S., Behring, A., Schlensak, C., Wendel, H. P., & Avci-Adali, M. (2018). Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs. Mol Ther Nucleic Acids, 13, 387–398. https://doi.org/10.1016/j.omtn.2018.09.005
doi: 10.1016/j.omtn.2018.09.005
pubmed: 30343252
pmcid: 6198099
Liu, Y., Yang, Y., Wang, Z., Fu, X., Chu, X. M., Li, Y., Wang, Q., He, X., Li, M., Wang, K., Wang, J. X., Li, P. F., & Yu, T. (2020). Insights into the regulatory role of circRNA in angiogenesis and clinical implications. Atherosclerosis, 298, 14–26. https://doi.org/10.1016/j.atherosclerosis.2020.02.017
doi: 10.1016/j.atherosclerosis.2020.02.017
pubmed: 32131039
Holdt, L. M., Stahringer, A., Sass, K., Pichler, G., Kulak, N. A., Wilfert, W., Kohlmaier, A., Herbst, A., Northoff, B. H., Nicolaou, A., Gabel, G., Beutner, F., Scholz, M., Thiery, J., Musunuru, K., Krohn, K., Mann, M., & Teupser, D. (2016). Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nature Communications, 7, 12429. https://doi.org/10.1038/ncomms12429
doi: 10.1038/ncomms12429
pubmed: 27539542
pmcid: 4992165
Bonnans, C., Chou, J., & Werb, Z. (2014). Remodelling the extracellular matrix in development and disease. Nature Reviews Molecular Cell Biology, 15, 786–801. https://doi.org/10.1038/nrm3904
doi: 10.1038/nrm3904
pubmed: 25415508
pmcid: 4316204
Minor, A. J., & Coulombe, K. L. K. (2020). Engineering a collagen matrix for cell-instructive regenerative angiogenesis. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. https://doi.org/10.1002/jbm.b.34573
doi: 10.1002/jbm.b.34573
pubmed: 31984665
pmcid: 7334070
Sekine, H., Shimizu, T., Hobo, K., Sekiya, S., Yang, J., Yamato, M., Kurosawa, H., Kobayashi, E., & Okano, T. (2008). Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation, 118, S145-152. https://doi.org/10.1161/circulationaha.107.757286
doi: 10.1161/circulationaha.107.757286
pubmed: 18824746
Madden, L. R., Mortisen, D. J., Sussman, E. M., Dupras, S. K., Fugate, J. A., Cuy, J. L., Hauch, K. D., Laflamme, M. A., Murry, C. E., & Ratner, B. D. (2010). Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A, 107, 15211–15216. https://doi.org/10.1073/pnas.1006442107
doi: 10.1073/pnas.1006442107
pubmed: 20696917
pmcid: 2930533
Munarin, F., & Coulombe, K. L. (2015). A novel 3-dimensional approach for cardiac regeneration. Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2015, 1741–1744. https://doi.org/10.1109/embc.2015.7318714
doi: 10.1109/embc.2015.7318714